Dose-Escalation, Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GB-6002 Local Infiltration in Healthy Male Adults

NCT06095973 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Postoperative

Interventions

DRUG: GB-6002
DRUG: Placebo
DRUG: Naropin injection

Sponsor

G2GBio, Inc.